These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 2455787)
1. Inhibition of exocrine pancreatic secretion by opiates is mediated by suppression of cholinergic transmission: characterization of receptor subtypes. Louie DS; Chen HT; Owyang C J Pharmacol Exp Ther; 1988 Jul; 246(1):132-6. PubMed ID: 2455787 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of cholinergic transmission by opiates in ileal myenteric plexus is mediated by kappa receptor. Involvement of regulatory inhibitory G protein and calcium N-channels. Kojima Y; Takahashi T; Fujina M; Owyang C J Pharmacol Exp Ther; 1994 Feb; 268(2):965-70. PubMed ID: 8114012 [TBL] [Abstract][Full Text] [Related]
3. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates. Fang FG; Fields HL; Lee NM J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217 [TBL] [Abstract][Full Text] [Related]
4. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883 [TBL] [Abstract][Full Text] [Related]
5. Mu and delta opioid receptors inhibit serotonin release in rat hippocampus. Passarelli F; Costa T J Pharmacol Exp Ther; 1989 Jan; 248(1):299-305. PubMed ID: 2536429 [TBL] [Abstract][Full Text] [Related]
6. Body temperature response profiles for selective mu, delta and kappa opioid agonists in restrained and unrestrained rats. Spencer RL; Hruby VJ; Burks TF J Pharmacol Exp Ther; 1988 Jul; 246(1):92-101. PubMed ID: 2839673 [TBL] [Abstract][Full Text] [Related]
7. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat. Fox DA; Burks TF J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341 [TBL] [Abstract][Full Text] [Related]
8. Modulation of cholinergic neurotransmission in guinea-pig airways by opioids. Belvisi MG; Stretton CD; Barnes PJ Br J Pharmacol; 1990 May; 100(1):131-7. PubMed ID: 1695531 [TBL] [Abstract][Full Text] [Related]
9. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system. Tao R; Auerbach SB J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635 [TBL] [Abstract][Full Text] [Related]
10. Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells. Jin W; Lee NM; Loh HH; Thayer SA Mol Pharmacol; 1992 Dec; 42(6):1083-9. PubMed ID: 1336113 [TBL] [Abstract][Full Text] [Related]
11. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156 [TBL] [Abstract][Full Text] [Related]
12. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo. Sheldon RJ; Nunan L; Porreca F J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899 [TBL] [Abstract][Full Text] [Related]
13. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. Latimer LG; Duffy P; Kalivas PW J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208 [TBL] [Abstract][Full Text] [Related]
14. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures. Tortella FC; Robles L; Mosberg HI J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318 [TBL] [Abstract][Full Text] [Related]
15. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460 [TBL] [Abstract][Full Text] [Related]
16. Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists. Matsumoto RR; Brinsfield KH; Patrick RL; Walker JM J Pharmacol Exp Ther; 1988 Jul; 246(1):196-203. PubMed ID: 2839661 [TBL] [Abstract][Full Text] [Related]
17. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine. Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814 [TBL] [Abstract][Full Text] [Related]
18. The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice. Welch SP; Singha AK; Dewey WL J Pharmacol Exp Ther; 1989 Oct; 251(1):1-8. PubMed ID: 2552070 [TBL] [Abstract][Full Text] [Related]
19. Opioid actions on neurons of rat lateral amygdala in vitro. Sugita S; North RA Brain Res; 1993 May; 612(1-2):151-5. PubMed ID: 8101129 [TBL] [Abstract][Full Text] [Related]
20. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation. Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]